Scholarly article on N-(2-methyl-4-((phenylsulfonyl)amino)phenyl)benzenesulfonamide 200348-81-8 from Journal of the American Chemical Society p. 4601,4605

DOI: 10.1021/ja01166a074

Source and publish data:

Journal of the American Chemical Society p. 4601,4605 (1950)

Update date:2022-08-03

Topics:

Authors:

Adams Adams

Nagarkatti

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01166a074

Full text of DOI:10.1021/ja01166a074

Products guided by the article

Product name:N-(2-methyl-4-((phenylsulfonyl)amino)phenyl)benzenesulfonamide

Cas No:200348-81-8

R&D Labs maybe for 200348-81-8

Beijing Green Guardee Technology CO,.LTD

Contact:+86-10-69706062

Address:F2 BLdj,5 No.37 Chaoqian Road
xujianqiang

Contact:86-21-57725962

Address:shanghai
SuZhou Yacoo Science Co., Ltd

Contact:86-512-87182055

Address:No.128 Fangzhou Rd, Suzhou Industrial Park, China, 215125, China
Zhenjiang Haitong Chemical Industry Co., Ltd.

Contact:+86 (511) 8448-0369

Address:Baoyan Town, Dantu District, Zhenjiang City, Jiangsu, China
Innua Petrochem Ltd.

Contact:+1-284-4950244

Address:Box 3069, Road Town, Tortola, British Virgin Islands

Relevant to this article

A new modification of 1,1′-Bis(diphenylphosphine oxide)ferrocene at 173 K

Doi:10.1107/S0108270197011207
(1997)
Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine

Doi:10.1016/S0006-2952(97)00403-6
(1997)
Synthesis of acetamides via oxidative C–C bond cleavage of ketones catalyzed by Cu-immobilized magnetic nanoparticles

Doi:10.1002/aoc.5855
(2020)
Total synthesis of the novel, immunosuppressive agent (-)-pateamine A from Mycale sp. employing a β-lactam-based macrocyclization

Doi:10.1021/ja973549f
(1998)
Enantioselective synthesis of 4-substituted 2-pyrrolidinones by site- selective C-H insertion of α-methoxycarbonyl-α-diazoacetanilides catalyzed by dirhodium(II) tetrakis[N-phthaloyl-(S)-tert-leucinate]

Doi:10.1016/S0040-4039(97)10493-2
(1998)
In vitrostudies of deferasirox derivatives as potential organelle-targeting traceable anti-cancer therapeutics

Doi:10.1039/d0cc08156f
(2021)

Article Doi

DOI: 10.1021/ja01166a074